MEGAN BLATTEL: Open Payments
NPI 1912424649 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$374 in 21 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $354 · 2025 $374
Food & beverage: $374
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $65 |
| Dendreon Pharmaceuticals LLC | 3 | $58 |
| Endo USA, Inc. | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $34 |
| ABBVIE INC. | 2 | $31 |
| Caris MPI, Inc. | 2 | $29 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| ACCORD HEALTHCARE, INC. | 1 | $15 |
Products named: ERLEADA, PROVENGE, XIAFLEX, Nubeqa, JOURNAVX, BOTOX, MI CANCER SEEK, KEYTRUDA QLEX.
Industry payments across MO — which companies pay providers there.
